XPNPEP2
Basic information
Region (hg38): X:129738949-129769536
Links
Phenotypes
GenCC
Source:
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Angioedema induced by ACE inhibitors, susceptibility to | XL | Pharmacogenomic | Medication selection would be impacted in individuals with relevant variants | General | 16175507 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the XPNPEP2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 7 | |||||
missense | 32 | 34 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 4 | |||||
Total | 0 | 0 | 32 | 9 | 4 |
Variants in XPNPEP2
This is a list of pathogenic ClinVar variants found in the XPNPEP2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
X-129739220-C-T | not specified | Likely benign (Oct 02, 2023) | ||
X-129741825-C-T | Benign (Nov 13, 2018) | |||
X-129742002-G-A | Benign (Nov 13, 2018) | |||
X-129742179-C-G | not specified | Uncertain significance (Nov 17, 2022) | ||
X-129745227-G-C | Uncertain significance (Dec 01, 2023) | |||
X-129745242-A-G | Uncertain significance (-) | |||
X-129746286-T-C | Uncertain significance (-) | |||
X-129746311-T-A | not specified | Uncertain significance (Aug 15, 2023) | ||
X-129746336-G-A | Uncertain significance (-) | |||
X-129746587-T-C | Likely benign (Jul 01, 2023) | |||
X-129746609-A-G | not specified | Uncertain significance (Jan 03, 2024) | ||
X-129746638-T-C | not specified | Benign (Mar 15, 2016) | ||
X-129746664-C-T | not specified | Uncertain significance (May 09, 2022) | ||
X-129747631-C-A | not specified | Uncertain significance (Nov 06, 2023) | ||
X-129747659-G-T | Likely benign (Mar 01, 2022) | |||
X-129747709-C-T | not specified | Uncertain significance (Jan 24, 2024) | ||
X-129750489-T-C | not specified | Uncertain significance (Dec 09, 2023) | ||
X-129750539-G-A | not specified | Uncertain significance (Dec 28, 2022) | ||
X-129750542-C-A | not specified | Uncertain significance (Jul 06, 2021) | ||
X-129751753-A-C | Susceptibility to angioedema induced by ACE inhibitors | Uncertain significance (Apr 04, 2024) | ||
X-129752170-G-A | not specified | Uncertain significance (Mar 04, 2024) | ||
X-129752186-C-T | Likely benign (Mar 01, 2023) | |||
X-129752253-C-T | not specified | Uncertain significance (Jan 31, 2024) | ||
X-129752323-G-A | not specified | Uncertain significance (Jan 18, 2023) | ||
X-129752356-C-T | not specified | Likely benign (Feb 04, 2016) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
XPNPEP2 | protein_coding | protein_coding | ENST00000371106 | 21 | 30565 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.87e-13 | 0.252 | 125666 | 36 | 45 | 125747 | 0.000322 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.338 | 288 | 272 | 1.06 | 0.0000216 | 4371 |
Missense in Polyphen | 94 | 92.749 | 1.0135 | 1432 | ||
Synonymous | -0.779 | 117 | 107 | 1.10 | 0.00000874 | 1325 |
Loss of Function | 1.10 | 23 | 29.4 | 0.782 | 0.00000214 | 465 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000484 | 0.000440 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00144 | 0.00109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000430 | 0.000308 |
Middle Eastern | 0.00144 | 0.00109 |
South Asian | 0.000737 | 0.000457 |
Other | 0.000442 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Membrane-bound metalloprotease which catalyzes the removal of a penultimate prolyl residue from the N-termini of peptides, such as Arg-Pro-Pro. May play a role in the metabolism of the vasodilator bradykinin. {ECO:0000269|PubMed:15361070}.;
- Disease
- DISEASE: Angioedema induced by ACE inhibitors (AEACEI) [MIM:300909]: A potentially life-threatening side effect of ACE inhibitors that appears in a subset of patients taking these drugs for hypertension and cardiovascular disease treatment. AEACEI is characterized by swelling of the face, lips, tongue, and airway that can lead to suffocation and death if severe. {ECO:0000269|PubMed:16175507, ECO:0000269|PubMed:20625347, ECO:0000269|PubMed:21898657}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.;
- Pathway
- Protein digestion and absorption - Homo sapiens (human);Post-translational modification: synthesis of GPI-anchored proteins;Post-translational protein modification;Metabolism of proteins
(Consensus)
Recessive Scores
- pRec
- 0.138
Intolerance Scores
- loftool
- 0.783
- rvis_EVS
- -0.38
- rvis_percentile_EVS
- 28.11
Haploinsufficiency Scores
- pHI
- 0.446
- hipred
- N
- hipred_score
- 0.281
- ghis
- 0.492
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.130
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Xpnpep2
- Phenotype
Gene ontology
- Biological process
- proteolysis
- Cellular component
- extracellular region;cytoplasm;plasma membrane;membrane;anchored component of membrane;extracellular exosome
- Molecular function
- aminopeptidase activity;metal ion binding;metalloaminopeptidase activity